The following stories appear in full on Today's Vidyya Medical News Service Web site.
According to a report in the current issue of The New England Journal of Medicine, scientists at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) have developed a new genetic test that, for the first time, can easily distinguish between hereditary and sporadic forms of breast cancer. This new approach should make it possible for physicians to quickly and accurately diagnose the cause of an individual woman's disease and may ultimately guide decisions about the most effective treatment.
For more information: Researchers Develop Gene Test That Differentiates Between Hereditary From Non-Hereditary Breast Cancer Types
Testing for the human papillomavirus (HPV) may help doctors and patients decide what to do about the mildly abnormal and very common Pap test result known as ASCUS. Findings from a major, randomized, multicenter study by the National Cancer Institute (NCI) show that HPV testing is highly sensitive in identifying which Pap-detected abnormalities require immediate attention.
For more information: HPV Testing Shows Which Pap Abnormalities Need Attention
ALTS is a clinical trial designed to find the best way to manage the mild abnormalities that often show up on Pap tests. The study began enrolling patients in November 1996 and completed enrollment in December 1998. Analysis of the data is under way. The most important finding of the study is that HPV testing identifies nearly all patients in need of immediate intervention following an abnormal pap smear. This question and answer sheet explains the trial in clear concise language and can help patients and practitioners determine the path of treatment.
For more information: Questions and Answers: ASCUS/LSIL Triage Study For Managment Of Abnormal Pap Smears
The composition of the vaccine for year 2001-2002 (Northern Hemisphere influenza season) has been decided and communicated to vaccine manufacturers by the World Health Organization (WHO), following agreement on its content by international experts at a WHO meeting held in Geneva, Switzerland this week. Read about the contents of the vaccine in today's issue.
For more information: Experts Decide Content Of 2001-2002 "Northern Hemisphere" Influenza Vaccine
The medical team responsible for the care of Jerry Fisher, the nation's second hand transplant recipient, today reported the initial movement of his fingers on the transplanted hand. In addition, the physicians said that a routine biopsy would be performed tomorrow to ensure that there are no signs of rejection.
For more information: World's Second Hand Transplant Recipient Moves Fingers For The First Time
Today's Vidyya articles are:
As always, we hope you enjoy the issue.